Spero Europe Limited

09738422

active

Private Limited Company

england wales

Companies House

Health Score

65 / 100

Some Concerns

25/30

Filing

0/30

Financial

40/40

Risk

No risk factors detected.

Details

6TH FLOOR, LONDON, EC2Y 5EB

Incorporated 18/08/2015

Compliance

Last accounts

31/12/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 03/08/2025

Due 17/08/2026

On track

Industry

72110

Research and experimental development on biotechnology

Officers

Ankit Atul Mahadevia

director · Since 18/08/2015

CEO

AMERICAN · UNITED STATES · Age 46

Also on 1 other board

Dr Patrick Volkert Jozef Johannes Vink

director · Since 15/10/2015

DIRECTOR

DUTCH · SWITZERLAND · Age 63

Persons with Significant Control

Spero Therapeutics, Inc

75–100% shares

75–100% votes

Appoint directors

PO BOX 02139, 675 Massachusetts Avenue, 14th Floor, Cambridge

Reg: 333220858 · Delaware · Public Limited Company

Notified 17/06/2017